CD38 inhibitors and methods of treatment
US9840496B2 · kind B2 · utility
0Cited by
0References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 19, 2015 |
| Grant date | Dec 12, 2017 |
| Priority date | — |
| Expiry date | Nov 19, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of Formula I and methods of treating diseases of metabolism by modulating cellular NAD+ levels through the inhibition of the CD38 enzyme, are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.